Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded “semaglutide”
New legal actions are directed at organizations involved in illegal activities, including violating laws prohibiting the corporate practice…